Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1998-11-09
2000-08-22
Fredman, Jeffrey
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
424 946, 4352541, 536 221, 536 231, 536 243, C12Q 168, A61K 3748, C12N 119, C07H 2102
Patent
active
061070408
ABSTRACT:
This invention provides methods for the discovery of molecules that target an essential aspect of eukaryotic gene expression--the formation of the mRNA 5' cap m7GpppN. An underlying principle of this invention is the use of a different strains of a test organism that differ only in the composition or source of the essential cap-forming enzymes. The invention provides isogenic yeast strains that derive all their capping activities from fungal sources versus mammalian sources. These strains form the basis of a differential growth inhibition assay to identify molecules that specifically target the fungal capping apparatus. This invention also provides a method to screen in vitro for molecules that inhibit fungal RNA triphosphatase, an essential enzyme that catalyzes the first of three steps in cap synthesis.
REFERENCES:
Yue et al., "Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylytransferase and selectively binds the elongating form of RNA polymerase II", vol. 94, pp. 12898-12903, Nov. 1997.
Ho et al, "Genetic, Physical, and Functional Interactions between the Triphosphatase and Guanylytransferase Components of the Yeast mRNA Capping Apparatus", Molecular and Cellular Biology, vol. 18(9), pp. 5189-5198, Sep. 1998.
Adler Benjamin Aaron
Chakrabarti Arun
Fredman Jeffrey
LandOfFree
Pharmacological targeting of mRNA cap formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacological targeting of mRNA cap formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological targeting of mRNA cap formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-579044